Antibody persistence six years after two doses of combined hepatitis A and B vaccine Read more about Antibody persistence six years after two doses of combined hepatitis A and B vaccine148 views
Perinatal transmission of hepatitis B virus: an Australian experience Read more about Perinatal transmission of hepatitis B virus: an Australian experience53 views
Tapping midwives' views about the neonatal hepatitis B vaccine: how welcome is a move towards a health promoting orientation? Read more about Tapping midwives' views about the neonatal hepatitis B vaccine: how welcome is a move towards a health promoting orientation? 34 views
Establishment of a surveillance system (utilising Midwifes Data Collection Systems) for monitoring the impact of hepatitis B vaccination on the population prevalence of chronic hepatitis B virus infection in Australia Read more about Establishment of a surveillance system (utilising Midwifes Data Collection Systems) for monitoring the impact of hepatitis B vaccination on the population prevalence of chronic hepatitis B virus infection in Australia23 views
Primary prevention of hepatitis B virus infection. In: Matthews G, Robotin M (eds). B positive – all you wanted to know about hepatitis B: a guide for primary care providers Read more about Primary prevention of hepatitis B virus infection. In: Matthews G, Robotin M (eds). B positive – all you wanted to know about hepatitis B: a guide for primary care providers54 views
The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia Read more about The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia43 views
Hepatitis B. In: The Cancer Council Australia. National Cancer Prevention Policy 2007–09 Read more about Hepatitis B. In: The Cancer Council Australia. National Cancer Prevention Policy 2007–09 28 views
Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11–15 years: a randomised controlled trial Read more about Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11–15 years: a randomised controlled trial47 views
Estimates of chronic hepatitis B virus infection in the Northern Territory Read more about Estimates of chronic hepatitis B virus infection in the Northern Territory49 views
Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study [letter] Read more about Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study [letter] 66 views